AgomAb Therapeutics NV (AGMB) stock
AGMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.92−0.05 (-0.84%)
Close on Nov 17, 2026Market cap $148.00KP/E –Yield –
AgomAb Therapeutics total assets
Total assets on the balance sheet at the end of each period.
AgomAb Therapeutics's total assets was €153.71M at Dec 31, 2025. For fiscal 2025 it was €153.71M, down 25.5% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €153.71M | -25.5% |
| FY2024 | Dec 31, 2024 | €206.36M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | €153.71M | – |
| Q4 FY2024 | Dec 31, 2024 | €206.36M | – |
See a number that looks wrong?